Jaguar Animal Health Inc (JAGX) - Total Assets
Based on the latest financial reports, Jaguar Animal Health Inc (JAGX) holds total assets worth $37.43 Million USD as of March 2026. Total assets represent everything the company owns and controls, combining both current assets—like cash and cash equivalents, accounts receivable, and inventories—and non-current assets such as property, plant, equipment (PP&E), intangible assets, and long-term investments. Explore cash flow to debt ratio of Jaguar Animal Health Inc to assess how comfortably operating cash covers total debt obligations.
Jaguar Animal Health Inc - Total Assets Trend (2007–2025)
This chart illustrates how Jaguar Animal Health Inc's total assets have evolved over time, based on quarterly financial data. See JAGX net asset value for net asset value and shareholders' equity analysis.
Jaguar Animal Health Inc - Asset Composition Analysis
Current Asset Composition (December 2025)
Jaguar Animal Health Inc's total assets of $37.43 Million consist of 53.1% current assets and 46.9% non-current assets.
| Asset Category | Amount (USD) | % of Total Assets |
|---|---|---|
| Cash & Equivalents | $0.00 | 2.5% |
| Accounts Receivable | $1.70 Million | 4.4% |
| Inventory | $8.60 Million | 22.4% |
| Property, Plant & Equipment | $0.00 | 0.0% |
| Intangible Assets | $16.02 Million | 41.8% |
| Goodwill | $0.00 | 0.0% |
Asset Composition Trend (2007–2025)
This chart illustrates how Jaguar Animal Health Inc's asset composition has evolved over time. Understanding changes in asset allocation can provide insights into the company's strategic shifts, capital allocation priorities, and business focus evolution. For live market cap, price, and company overview, see how much is Jaguar Animal Health Inc worth.
Key Asset Composition Facts
- Current vs. Non-Current Assets: Jaguar Animal Health Inc's current assets represent 53.1% of total assets in 2025, a decrease from 79.4% in 2007.
- Cash Position: Cash and equivalents constituted 2.5% of total assets in 2025, down from 14.6% in 2007.
- Tangible vs. Intangible: Intangible assets (including goodwill) make up 41.0% of total assets, an increase from 14.0% in 2007.
- Asset Diversification: The largest asset category is intangible assets at 41.8% of total assets.
Jaguar Animal Health Inc Competitors by Total Assets
Key competitors of Jaguar Animal Health Inc based on total assets are shown below.
| Company | Country | Total Assets |
|---|---|---|
|
Prostemics Co. Ltd
KQ:203690
|
Korea | ₩39.70 Billion |
|
ORUM
KQ:475830
|
Korea | ₩191.52 Billion |
|
TELIX Pharmaceuticals Ltd
AU:TLX
|
Australia | AU$1.19 Billion |
|
TG Therapeutics Inc
NASDAQ:TGTX
|
USA | $1.53 Billion |
|
Green Cross Holdings Preference Shares
KO:005257
|
Korea | ₩4.12 Trillion |
|
Rocket Pharmaceuticals Inc
NASDAQ:RCKT
|
USA | $285.41 Million |
|
NEWRON PHARMACEUT. EO-20
XETRA:NP5
|
Germany | €40.03 Million |
|
Cybin Inc
NEO:CYBN
|
Canada | CA$290.11 Million |
Jaguar Animal Health Inc - Liquidity and Working Capital Analysis
Liquidity ratios measure a company's ability to pay off its short-term debts as they come due, using the company's current or quick assets. Working capital represents the operational liquidity available.
Key Liquidity Metrics
| Metric | Current | 1 Year Ago | 5 Years Ago |
|---|---|---|---|
| Current Ratio | 0.50 | 1.08 | 3.50 |
| Quick Ratio | 0.30 | 0.70 | 3.23 |
| Cash Ratio | 0.00 | 0.00 | 0.00 |
| Working Capital | $-20.48 Million | $2.23 Million | $31.64 Million |
Jaguar Animal Health Inc - Advanced Valuation Insights
This section examines the relationship between Jaguar Animal Health Inc's asset base and its market valuation, helping to identify whether the company's assets are efficiently translated into market value.
Key Valuation Metrics
| Current Price-to-Book Ratio | 1.62 |
| Latest Market Cap to Assets Ratio | 0.12 |
| Asset Growth Rate (YoY) | -28.3% |
| Total Assets | $38.32 Million |
| Market Capitalization | $4.56 Million USD |
Valuation Analysis
Below Book Valuation: The market values Jaguar Animal Health Inc's assets below their book value (0.12x), which may indicate investor concerns about asset quality or future growth.
Significant Asset Reduction: Jaguar Animal Health Inc's assets decreased by 28.3% over the past year, potentially indicating divestiture, restructuring, or challenging business conditions.
Annual Total Assets for Jaguar Animal Health Inc (2007–2025)
The table below shows the annual total assets of Jaguar Animal Health Inc from 2007 to 2025.
| Year | Total Assets | Change |
|---|---|---|
| 2025-12-31 | $38.32 Million | -28.27% |
| 2024-12-31 | $53.42 Million | +5.24% |
| 2023-12-31 | $50.76 Million | +6.98% |
| 2022-12-31 | $47.45 Million | -10.91% |
| 2021-12-31 | $53.27 Million | +24.33% |
| 2020-12-31 | $42.84 Million | +17.67% |
| 2019-12-31 | $36.41 Million | -11.29% |
| 2018-12-31 | $41.04 Million | -5.93% |
| 2017-12-31 | $43.63 Million | +1124.46% |
| 2016-12-31 | $3.56 Million | -71.28% |
| 2015-12-31 | $12.41 Million | +115.49% |
| 2014-12-31 | $5.76 Million | +1890.12% |
| 2013-12-31 | $289.26K | -97.19% |
| 2007-12-31 | $10.30 Million | -- |
About Jaguar Animal Health Inc
Jaguar Health, Inc., a commercial-stage pharmaceuticals company, focuses on developing plant-based prescription medicines for people and animals with gastrointestinal distress. It operates through two segments, Animal Health and Human Health. The company focuses on developing and commercializing prescription and non-prescription products for companion and production animals; and human products. I… Read more